Sort by
Refine Your Search
-
(FSTM) at the University of Luxembourg contributes multidisciplinary expertise in the fields of Mathematics, Physics, Engineering, Computer Science, Life Sciences and Medicine. Through its dual mission
-
; Participate in lab meetings and scientific discussions. Key Skills, Experience & Qualifications Education & Experience: Enrolled in a Master’s programme (M2) in biology, immunology, oncology, or a closely
-
(FSTM) at the University of Luxembourg contributes multidisciplinary expertise in the fields of Mathematics, Physics, Engineering, Computer Science, Life Sciences and Medicine. Through its dual mission
-
interdisciplinary, and together we contribute to science and society. Your role Successful candidate will join the Clinical and Translational Informatics group, led by Dr. Venkata Satagopam, which focuses on bridging
-
interdisciplinary, and together we contribute to science and society. Your role Successful candidate will join the Clinical and Translational Informatics group, led by Dr. Venkata Satagopam, which focuses on bridging
-
on Neural Information Processing System [20] Anish Agarwal, Munther Dahleh, and Tuhin Sarkar, A marketplace for data: An algorithmic solution, in Proceedings of the 2019 ACM Conference on Economics and
-
Master’s degree in Health Engineering is recommended. ➢ Proficiency in English is recommended. The desired profile combines scientific rigor, the ability to work independently, and team spirit within a
-
(FSTM) at the University of Luxembourg contributes multidisciplinary expertise in the fields of Mathematics, Physics, Engineering, Computer Science, Life Sciences and Medicine. Through its dual mission
-
(LCSB) is an interdisciplinary research centre of the University of Luxembourg. We conduct fundamental and translational research in the field of Systems Biology and Biomedicine - in the lab, in
-
pool of leukemic cells in sanctuary lymphoid organs leading to transformation in high-grade lymphomas. 3) the elaboration of computational prediction tools of progression and new preclinical models